The massive discount and potential for up to 200% additional shares via the 60-day option signal severe capital needs and likely further dilution. Monitor the filing of H1 2026 financials, which triggers the additional allocation right. The loss of 'controlled company' status may reduce governance protections but does not offset the dilutive impact.
Price Chart
Executive Summary
NCI is conducting a dilutive registered direct offering of 250,000 Class A Ordinary Shares at $1.00/share and 1,750,000 pre-funded warrants at $0.99/warrant, for gross proceeds of $2.0 million. The offering price represents a ~93% discount to the last closing price of $14.65. The purchaser also has a 60-day option to buy up to 200% additional securities at the same price. The company will cease to be a 'controlled company' post-offering as CEO Pengfei Jiang's voting power drops from 63.2% to 48.6%.
Key Facts
- Offering of 250,000 Class A Ordinary Shares at $1.00/share and 1,750,000 pre-funded warrants at $0.99/warrant for gross proceeds of $2.0 million.
- Offering price is a ~93% discount to the last closing price of $14.65 on September 25, 2026.
- Net proceeds estimated at ~$1.81 million after placement agent fees ($140,000) and estimated expenses ($190,000).
- Purchaser has a 60-day option to buy up to 200% additional securities at the same price, contingent on filing of H1 2026 financials.
- Post-offering, CEO Pengfei Jiang's voting power drops from 63.2% to 48.6%, and the company ceases to be a 'controlled company'.
- Existing shareholders experience an immediate $2.07 decrease in net tangible book value per share.
- The company had accumulated losses of $6.42 million as of December 31, 2025.
- Pre-funded warrants are immediately exercisable at $0.01/share and do not expire until exercised in full.
Financial Impact
Gross proceeds of $2.0 million at a ~93% discount to market price; net proceeds of ~$1.81 million for working capital. Immediate dilution of $2.07 per share to existing holders.
Risk Factors
- Extreme dilution from the discounted offering and potential additional 200% allocation.
- Stock price likely to trade down toward the $1.00 offering price.
- No established market for the pre-funded warrants limits liquidity.
- Company has a history of accumulated losses and relies on dilutive financing.
- PRC regulatory uncertainty could impact operations despite no current Mainland China business.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001185185-26-004478 |
| Document: 0001185185-26-004478-index-headers.html | 0001185185-26-004478 |
| Document: 0001185185-26-004478-index.html | 0001185185-26-004478 |
| Document: 0001185185-26-004478.txt | 0001185185-26-004478 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $0.8200 | awaiting T+5 | — | $0.8490 (−3.54%) |
Oct 16, 2026 11d ago | 6-K | $0.6111 $0.7903 | ▼ −29.32% | ▼ −29.75% | $0.8490 (−38.93%) |
Oct 16, 2026 11d ago | 6-K | $0.6111 $0.7903 | ▼ −29.32% | ▼ −29.75% | $0.8490 (−38.93%) |
Oct 7, 2026 19d ago | SC 13G | $0.8808 $0.6890 | ▼ −21.78% | ▼ −21.50% | $0.8490 (−3.61%) |
Oct 5, 2026 22d ago | 6-K | $0.9231 $0.7602 | ▼ −17.65% | ▼ −18.07% | $0.8490 (−8.03%) |
Oct 1, 2026 25d ago | 6-K | $0.8619 $0.8788 | ▼ −1.96% | ▼ −0.80% | $0.8490 (+1.50%) |
Oct 1, 2026 26d ago | 424B5 | $1.06 $0.8808 | ▲ +16.91% | ▲ +18.21% | $0.8490 (+19.91%) |
Sep 16, 2026 5w ago | 6-K | $13.33 $14.60 | ▼ −9.57% | ▼ −7.49% | $0.8490 (+93.63%) |
Aug 26, 2026 8w ago | 6-K | $12.20 $13.48 | ▼ −10.49% | ▼ −10.61% | $0.8490 (+93.04%) |
Aug 19, 2026 9w ago | 6-K | $12.35 $12.20 | ▲ +1.21% | ▲ +0.83% | $0.8490 (+93.13%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers